IBIO
NASD iBio, Inc.$0.9032 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9032, $0.0468 below the day’s high of $0.9500
- YTD change
- -53.20%
- vs 20-day SMA
- -21.63%
- vs 200-day SMA
- -49.66%
Price ranges
Price & Performance
-1.30 (-58.95%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $3,725.0000
- IBIO is down 53% since the beginning of the year
- IBIO is up 14% over the past 12 months
- IBIO is down 25% over the past 1 month
- 8% of all IBIO investors are betting against IBIO
IBIO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +11.7%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0255
- Last 5 days
- -19.72%
- vs 8-day SMA
- -13.84%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
